Evaluation of the Effect of the Association of Proton Pump Inhibitor (PPIs) With Non-Steriodal Anti-Inflamatories (NSAIDs) in Work Leave Time.
This study has been completed.
Sponsor:
AstraZeneca
Collaborator:
Ibermutuamur M.A.T.E.P.S
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00717119
First received: July 14, 2008
Last updated: September 12, 2008
Last verified: July 2008
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | July 14, 2008 | ||||
| Last Updated Date | September 12, 2008 | ||||
| Start Date ICMJE | April 2008 | ||||
| Primary Completion Date | Not Provided | ||||
| Current Primary Outcome Measures ICMJE |
Total work leave time [ Time Frame: Jan 2007 to Dec 2007 ] [ Designated as safety issue: No ] | ||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | Complete list of historical versions of study NCT00717119 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE |
|
||||
| Original Secondary Outcome Measures ICMJE | Same as current | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Evaluation of the Effect of the Association of Proton Pump Inhibitor (PPIs) With Non-Steriodal Anti-Inflamatories (NSAIDs) in Work Leave Time. | ||||
| Official Title ICMJE | Evaluation of the Effect of the Association of Proton Pump Inhibitor (PPIs) With Non-Steriodal Anti-Inflamatories (NSAIDs) in Work Leave Time. | ||||
| Brief Summary | Retrospective cohort study to evaluate the effect of the association of PPIs with NSAIDs in work leave time. |
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Cohort Time Perspective: Retrospective |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Not Provided | ||||
| Sampling Method | Non-Probability Sample | ||||
| Study Population | Data base of patients with work leave due to a sprain of ankle |
||||
| Condition ICMJE | Sprain of Ankle | ||||
| Intervention ICMJE | Not Provided | ||||
| Study Group/Cohort (s) | 1
Patients with sprain of ankle treated with NSAID |
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Enrollment ICMJE | 6356 | ||||
| Completion Date | August 2008 | ||||
| Primary Completion Date | Not Provided | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | Not Provided | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | Spain | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT00717119 | ||||
| Other Study ID Numbers ICMJE | NIS-GES-DUM-2008/3 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Mónica Tafalla/MD, PhD, AstraZeneca Pharmaceuticals | ||||
| Study Sponsor ICMJE | AstraZeneca | ||||
| Collaborators ICMJE | Ibermutuamur M.A.T.E.P.S | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | AstraZeneca | ||||
| Verification Date | July 2008 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||